【レポートの概要（一部）】
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Top Player Positioning, 2018
3.4. Porter’S Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. High Investment For R&D Activities Pertaining To Gene Therapy
3.5.1.2. Increase In Prevalence of Cancer
3.5.1.3. Growth In Awareness Regarding Gene Therapy
3.5.2. Restraints
3.5.2.1. High Cost Associated With Gene Therapies
3.5.2.2. Unwanted Immune Responses
3.5.3. Opportunities
3.5.3.1. Untapped Potential For Emerging Markets
Chapter 4: Gene Therapy Market, By Vector Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Viral Vectors
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Size And Forecast, By Type
4.2.4. Market Size And Forecast, By Country
4.2.5. Adenovirus
4.2.6. Lentivirus
4.2.7. Retrovirus
4.2.8. Adeno-Associated Virus
4.2.9. Herpes Simplex Virus
4.2.10. Poxvirus
4.2.11. Vaccinia Virus
4.2.12. Others
4.3. Non-Viral Techniques
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Size And Forecast, By Type
4.3.4. Market Size And Forecast, By Country
4.3.5. Naked Plasmid Vector
4.3.6. Gene Gun
4.3.7. Electroporation
4.3.8. Lipofection
4.3.9. Others
Chapter 5: Gene Therapy Market, By Gene Type
5.1. Overview
5.1.1. Market Size And Forecast, Type
5.2. Antigen
5.2.1. Market Size And Forecast
5.2.2. Market Size And Forecast, By Country
5.3. Cytokine
5.3.1. Market Size And Forecast
5.3.2. Market Size And Forecast, By Country
5.4. Tumor Suppressor
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Size And Forecast, By Country
5.5. Suicide Gene
5.5.1. Market Size And Forecast
5.5.2. Market Size And Forecast, By Country
5.6. Deficiency
5.6.1. Market Size And Forecast, By Region
5.6.2. Market Size And Forecast, By Country
5.7. Growth Factors
5.7.1. Market Size And Forecast, By Region
5.7.2. Market Size And Forecast, By Country
5.8. Receptors
5.8.1. Market Size And Forecast, By Region
5.8.2. Market Size And Forecast, By Country
5.9. Others
5.9.1. Market Size And Forecast, By Region
5.9.2. Market Size And Forecast, By Country
Chapter 6: Gene Therapy Market, By Application
6.1. Overview
6.1.1. Market Size And Forecast, By Application
6.2. Oncological Disorders
6.2.1. Market Size And Forecast, By Region
6.2.2. Market Size And Forecast, By Country
6.3. Rare Diseases
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Size And Forecast, By Country
6.4. Cardiovascular Diseases
6.4.1. Market Size And Forecast, By Region
6.4.2. Market Size And Forecast, By Country
6.5. Neurological Disorders
6.5.1. Market Size And Forecast
6.5.2. Market Size And Forecast, By Country
6.6. Infectious Diseases
6.6.1. Market Size And Forecast, By Region
6.6.2. Market Size And Forecast, By Country
6.7. Other Diseases
6.7.1. Market Size And Forecast
6.7.2. Market Size And Forecast, By Country
Chapter 7: Gene Therapy Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.3. Market Size And Forecast, By Vector Type
7.2.4. Market Size And Forecast, By Gene Type
7.2.5. Market Size And Forecast, By Application
7.2.5.1. U.S. Market Size And Forecast, By Vector Type
7.2.5.2. U.S. Market Size And Forecast, By Gene Type
7.2.5.3. U.S. Market Size And Forecast, By Application
7.2.5.4. Canada Market Size And Forecast, By Vector Type
7.2.5.5. Canada Market Size And Forecast, By Gene Type
7.2.5.6. Canada Market Size And Forecast, By Application
7.2.5.7. Mexico Market Size And Forecast, By Vector Type
7.2.5.8. Mexico Market Size And Forecast, By Gene Type
7.2.5.9. Mexico Market Size And Forecast, By Application
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.3. Market Size And Forecast, By Vector Type
7.3.4. Market Size And Forecast, By Gene Type
7.3.5. Market Size And Forecast, By Application
7.3.5.1. Germany Market Size And Forecast, By Vector Type
7.3.5.2. Germany Market Size And Forecast, By Gene Type
7.3.5.3. Germany Market Size And Forecast, By Application
7.3.5.4. France Market Size And Forecast, By Vector Type
7.3.5.5. France Market Size And Forecast, By Gene Type
7.3.5.6. France Market Size And Forecast, By Application
7.3.5.7. Uk Market Size And Forecast, By Vector Type
7.3.5.8. Uk Market Size And Forecast, By Gene Type
7.3.5.9. Uk Market Size And Forecast, By Application
7.3.5.10. Italy Market Size And Forecast, By Vector Type
7.3.5.11. Italy Market Size And Forecast, By Gene Type
7.3.5.12. Italy Market Size And Forecast, By Application
7.3.5.13. Spain Market Size And Forecast, By Vector Type
7.3.5.14. Spain Market Size And Forecast, By Gene Type
7.3.5.15. Spain Market Size And Forecast, By Application
7.3.5.16. Rest of Europe Market Size And Forecast, By Vector Type
7.3.5.17. Rest of Europe Market Size And Forecast, By Gene Type
7.3.5.18. Rest of Europe Market Size And Forecast, By Application
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.3. Market Size And Forecast, By Vector Type
7.4.4. Market Size And Forecast, By Gene Type
7.4.5. Market Size And Forecast, By Application
7.4.5.1. Japan Market Size And Forecast, By Vector Type
7.4.5.2. Japan Market Size And Forecast, By Gene Type
7.4.5.3. Japan Market Size And Forecast, By Application
7.4.5.4. China Market Size And Forecast, By Vector Type
7.4.5.5. China Market Size And Forecast, By Gene Type
7.4.5.6. China Market Size And Forecast, By Application
7.4.5.7. India Market Size And Forecast, By Vector Type
7.4.5.8. India Market Size And Forecast, By Gene Type
7.4.5.9. India Market Size And Forecast, By Application
7.4.5.10. South Korea Market Size And Forecast, By Vector Type
7.4.5.11. South Korea Market Size And Forecast, By Gene Type
7.4.5.12. South Korea Market Size And Forecast, By Application
7.4.5.13. Rest of Asia-Pacific Market Size And Forecast, By Vector Type
7.4.5.14. Rest of Asia-Pacific Market Size And Forecast, By Gene Type
7.4.5.15. Rest of Asia-Pacific Market Size And Forecast, By Application
7.5. Lamea
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.3. Market Size And Forecast, By Vector Type
7.5.4. Market Size And Forecast, By Gene Type
7.5.5. Market Size And Forecast, By Application
7.5.5.1. Brazil Market Size And Forecast, By Vector Type
7.5.5.2. Brazil Market Size And Forecast, By Gene Type
7.5.5.3. Brazil Market Size And Forecast, By Application
7.5.5.4. South Africa Market Size And Forecast, By Vector Type
7.5.5.5. South Africa Market Size And Forecast, By Gene Type
7.5.5.6. South Africa Market Size And Forecast, By Application
7.5.5.7. Rest of Lamea Market Size And Forecast, By Vector Type
7.5.5.8. Rest of Lamea Market Size And Forecast, By Gene Type
7.5.5.9. Rest of Lamea Market Size And Forecast, By Application
Chapter 8: Company Profile
8.1. Adaptimmune Therapeutics Plc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.1.6. Key Strategic Moves And Developments
8.2. Anchiano Therapeutics Ltd.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.3. Achieve Life Sciences, Inc.
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Key Strategic Moves And Developments
8.4. Adverum Biotechnologies, Inc.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Key Strategic Moves And Developments
8.5. Abeona Therapeutics Inc.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.5.6. Key Strategic Moves And Developments
8.6. Applied Genetic Technologies Corporation
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.6.6. Key Strategic Moves And Developments
8.7. Arbutus Biopharma Corporation
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Product Portfolio
8.7.4. Business Performance
8.7.5. Key Strategic Moves And Developments
8.8. Audentes Therapeutics Inc.
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Product Portfolio
8.8.4. Key Strategic Moves And Developments
8.9. Avexis Inc.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Product Portfolio
8.9.4. Key Strategic Moves And Developments
8.10. Bluebird Bio, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
8.10.6. Key Strategic Moves And Developments
8.11. Celgene Corporation
8.11.1. Company Overview
8.11.2. Company Snapshot
8.11.3. Operating Business Segments
8.11.4. Product Portfolio
8.11.5. Business Performance
8.11.6. Key Strategic Moves And Developments
8.12. Crispr Therapeutics Ag
8.12.1. Company Overview
8.12.2. Company Snapshot
8.12.3. Product Portfolio
8.12.4. Business Performance
8.12.5. Key Strategic Moves And Developments
8.13. Editas Medicine, Inc.
8.13.1. Company Overview
8.13.2. Company Snapshot
8.13.3. Operating Business Segments
8.13.4. Product Portfolio
8.13.5. Business Performance
8.13.6. Key Strategic Moves And Developments
8.14. Gilead Sciences, Inc.
8.14.1. Company Overview
8.14.2. Company Snapshot
8.14.3. Operating Business Segments
8.14.4. Product Portfolio
8.14.5. Business Performance
8.14.6. Key Strategic Moves And Developments
8.15. Glaxosmithkline Plc
8.15.1. Company Overview
8.15.2. Company Snapshot
8.15.3. Operating Business Segments
8.15.4. Product Portfolio
8.15.5. Business Performance
8.15.6. Key Strategic Moves And Developments
8.16. Intellia Therapeutics Inc.
8.16.1. Company Overview
8.16.2. Company Snapshot
8.16.3. Operating Business Segments
8.16.4. Product Portfolio
8.16.5. Business Performance
8.16.6. Key Strategic Moves And Developments
8.17. Merck & Co., Inc.
8.17.1. Company Overview
8.17.2. Company Snapshot
8.17.3. Operating Business Segments
8.17.4. Product Portfolio
8.17.5. Business Performance
8.17.6. Key Strategic Moves And Developments
8.18. Novartis Ag
8.18.1. Company Overview
8.18.2. Company Snapshot
8.18.3. Operating Business Segments
8.18.4. Product Portfolio
8.18.5. Business Performance
8.18.6. Key Strategic Moves And Developments
8.19. Regenxbio, Inc.
8.19.1. Company Overview
8.19.2. Company Snapshot
8.19.3. Product Portfolio
8.19.4. Business Performance
8.19.5. Key Strategic Moves And Developments
8.20. Spark Therapeutics, Inc.
8.20.1. Company Overview
8.20.2. Company Snapshot
8.20.3. Operating Business Segments
8.20.4. Product Portfolio
8.20.5. Business Performance
8.20.6. Key Strategic Moves And Developments
8.21. Sangamo Therapeutics, Inc.
8.21.1. Company Overview
8.21.2. Company Snapshot
8.21.3. Operating Business Segments
8.21.4. Product Portfolio
8.21.5. Business Performance
8.21.6. Key Strategic Moves And Developments
8.22. Uniqure N. V.
8.22.1. Company Overview
8.22.2. Company Snapshot
8.22.3. Operation Segments
8.22.4. Product Portfolio
8.22.5. Business Performance
8.22.6. Key Strategic Moves And Developments
8.23. Voyager Therapeutics, Inc.
8.23.1. Company Overview
8.23.2. Company Snapshot
8.23.3. Operating Business Segments
8.23.4. Product Portfolio
8.23.5. Business Performance
8.23.6. Key Strategic Moves And Developments
【レポート販売概要】
■ タイトル：遺伝子治療の世界市場：ベクター種類別（ウイルスベクター、非ウイルスベクター）、遺伝子種類別（抗原、サイトカイン、腫瘍抑制因子、自殺、欠乏、成長因子、受容体、その他）、用途別（腫瘍性疾患、希少疾患、心血管疾患、神経疾患、感染症、その他）■ 英文：Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年12月31日
■ 調査会社：Allied Market Research
■ 商品コード：AMR20FE041
■ 調査対象地域：グローバル
- The Apple iPad: New Standard for Mobile Computing & Wireless ExpectationsThe Apple iPad is an innovative computing tablet that is expected to cause a substantial ripple in information technology in the area of notebooks and wireless communications. Its allure lies in its technological innovations, purported to provide the ultimate web and computing experience in a simple, portable package. Brand loyalty among Apple customers will certainly make up the bulk of initial s …
- 尿道拡張器の世界市場2019-2023About this market Urethral stricture is a chronic disease in which the urethral opening becomes narrow due to injuries, scars, genetic disorders, and infections such as sexual transmitted diseases (STDs). These strictures are a common problem and can be initially treated with urethral dilation. Urethral stricture treatment is driven by the growing number of treatments for kidney stones, prostate c …
- オンコセルカ症(河川盲目症)(Onchocerciasis (River Blindness))：世界の治験レビュー2014年下半期版Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014" provides data on the Onchocerciasis (River Blindness) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Onchocerciasis (River Blindness). It inclu …
- 非小細胞肺癌：世界の臨床試験レビュー（2014年上半期）Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Small Cell Lung Cancer. It includes an overview of the t …
- 統合ネットワーク管理の世界市場：有線、無線The unified network management market is estimated to grow from USD 5.01 Billion in 2016 to USD 12.32 Billion by 2021. The market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) of 19.7% owing to the rising usage of unified networking solutions among organizations to manage and control wireline or wireless networking activities. Companies are deploying unified networking so …
- T&D（送電・配電）装置のヨーロッパ市場2017-2021About T&D equipmentTransmission and distribution (T&D) infrastructure supplies electricity to power substations and then to the electric utility, which delivers electricity to industrial and domestic consumers. Technavio’s analysts forecast the T&D equipment market in Europe to grow at a CAGR of 3.55% during the period 2017-2021. [Covered in this report] The report covers the present scenario and …
- アフリカ南部地域の石油・ガス市場Visiongain has calculated that the Southern African oil and gas market will see capex of $18.55bn in 2015, including spending on both upstream exploration & development (E&D) and midstream infrastructure. Southern Africa is the single largest region of Africa, a region that includes a diverse range of economies all at varying stages in terms of oil and gas industry development. OPEC member Angola …
- 世界の産業用組込みシステム市場（2011-2015）TechNavio's analysts forecast the Global Industrial Embedded Systems market to grow at a CAGR of 9.44 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing focus on enhancing productivity. The Global Industrial Embedded Systems market has also been witnessing increasing demand from the Telecom sector. However, the inability to meet the deman …
- 液体包装用板紙の世界市場2016-2020About Liquid Packaging Board Liquid packaging board has a high barrier coating to contain the liquid. It also resists the air and flavor from the paperboard to mix into the contained liquid. Manufacturing companies make continuous innovations for creating economic and environment-friendly packaging. Liquid packaging board is used in packaging of dairy products, dilutable, juices, household care pr …
- 軍用バイオメトリクス（生体認証）の世界市場2016-2020：指紋識別生体認証、顔認識生体認証、虹彩認識生体認証About Military Biometrics Over the last decade, there has been an increase in the number of insurgent and criminal activities and attacks across the globe. This has prompted the governments of a majority of the countries to invest considerably in enhancing the surveillance and monitoring systems through the purchase of new biometric equipment and related technologies. In addition, the growing inst …
- 輸送・流通分野におけるRTLSの世界市場2016-2020：RFID、Wi-Fi、バーコード、QRコードAbout RTLS RTLS is the technology used to find, track, manage, and identify the geographical position of a target on a real-time basis with the help of nodes/tags and readers. Nodes or tags are embedded in smartphones or navigational devices, through which a user can easily track an object. A reader is used to receive wireless signals from the tags, through which an object can be located. RTLS wor …
- バイオ系建築用ポリマーの世界市場分析：製品別（セルロースアセテート、エポキシ、ポリエチレンテレフタレート（PET）、ポリウレタン）、用途別（パイプ、外郭、断熱）、セグメント予測The global bio based construction polymers market is expected to reach USD 33.26 billion by 2024 according to a new report by Grand View Research, Inc. Rising bio-based polymer demand in various applications in the construction sector such as cladding panel, FRP bridge section, and glazing sealant is expected to remain a key driving force for the market growth. Increasing regulatory intervention t …
- 世界の金属製伸縮継手市場2015The Global Metal Expansion Joints Industry Report 2015 is a professional and in-depth study on the current state of the Metal Expansion Joints industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Metal Expansion Joints market analysis is provided for the international markets including development tren …
- 自動車燃料タンクの世界市場：樹脂製タンク、金属製タンクThe global automotive fuel tank market is estimated to be valued at $3,522.7 million in 2014 and is projected to grow to at a CAGR of 5.85% from 2014–2019. The automotive fuel tank market is primarily growing due to increasing vehicle demand. The technological innovations in this market are being pushed by increasing pressure by government authorities to develop lightweight and less permeable fuel …
- Gran Tierra Energy Inc.：石油・ガスバリューチェーン分析レポート2013Gran Tierra Energy Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Gran Tierra Energy Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Gran Tierra Energy Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The re …
